PCVX
Price
$56.90
Change
+$0.21 (+0.37%)
Updated
Sep 30 closing price
Capitalization
8.67B
39 days until earnings call
Intraday BUY SELL Signals
PTCT
Price
$64.78
Change
-$0.18 (-0.28%)
Updated
Sep 30 closing price
Capitalization
5.5B
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PCVX vs PTCT

PCVX vs PTCT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PCVX vs. PTCT commentary
Oct 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Hold and PTCT is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PCVX vs PTCT: Fundamental Ratings
PCVX
PTCT
OUTLOOK RATING
1..100
2263
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
7867
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4561
P/E GROWTH RATING
1..100
3630
SEASONALITY SCORE
1..100
48n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PCVX's Valuation (67) in the null industry is in the same range as PTCT (99) in the Biotechnology industry. This means that PCVX’s stock grew similarly to PTCT’s over the last 12 months.

PTCT's Profit vs Risk Rating (67) in the Biotechnology industry is in the same range as PCVX (78) in the null industry. This means that PTCT’s stock grew similarly to PCVX’s over the last 12 months.

PCVX's SMR Rating (96) in the null industry is in the same range as PTCT (100) in the Biotechnology industry. This means that PCVX’s stock grew similarly to PTCT’s over the last 12 months.

PCVX's Price Growth Rating (45) in the null industry is in the same range as PTCT (61) in the Biotechnology industry. This means that PCVX’s stock grew similarly to PTCT’s over the last 12 months.

PTCT's P/E Growth Rating (30) in the Biotechnology industry is in the same range as PCVX (36) in the null industry. This means that PTCT’s stock grew similarly to PCVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PCVXPTCT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
70%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
72%
COMPARISON
Comparison
Oct 01, 2026
Stock price -- (PCVX: $56.90 vs. PTCT: $64.78)
Brand notoriety: PCVX and PTCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 142% vs. PTCT: 86%
Market capitalization -- PCVX: $8.67B vs. PTCT: $5.5B
PCVX [@Biotechnology] is valued at $8.67B. PTCT’s [@Biotechnology] market capitalization is $5.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green while PTCT’s FA Score has 1 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • PTCT’s FA Score: 1 green, 4 red.
According to our system of comparison, PCVX is a better buy in the long-term than PTCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 3 TA indicator(s) are bullish while PTCT’s TA Score has 5 bullish TA indicator(s).

  • PCVX’s TA Score: 3 bullish, 6 bearish.
  • PTCT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PTCT is a better buy in the short-term than PCVX.

Price Growth

PCVX (@Biotechnology) experienced а +0.72% price change this week, while PTCT (@Biotechnology) price change was +3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.67%. For the same industry, the average monthly price growth was -10.91%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

PCVX is expected to report earnings on Nov 09, 2026.

PTCT is expected to report earnings on Oct 22, 2026.

Industries' Descriptions

@Biotechnology (-2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
PCVX
Daily Signal:
Gain/Loss:
PTCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MUA9.550.15
+1.60%
Blackrock Muni Assets Fund
GF10.640.03
+0.28%
NEW Germany Fund
IXN148.220.34
+0.23%
iShares Global Tech ETF (IXN)
QSML32.42N/A
+0.01%
WisdomTree U.S. SmallCap Quality Growth Fund (QSML)
QVOY28.07-0.13
-0.45%
Q3 All-Season Active Rotation ETF (QVOY)

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with SRRK. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+0.37%
SRRK - PCVX
49%
Loosely correlated
+1.19%
BCYC - PCVX
48%
Loosely correlated
+0.82%
DNLI - PCVX
47%
Loosely correlated
-0.67%
VIR - PCVX
46%
Loosely correlated
+4.98%
MIRM - PCVX
45%
Loosely correlated
-2.35%
More